Metro Healthcare Indonesia Tbk PT
IDX:CARE
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
75
193
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Metro Healthcare Indonesia Tbk PT
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | ID |
Market Cap | 5.2T IDR |
Net Margin |
-37%
|
Country | US |
Market Cap | 83.9B USD |
Net Margin |
9%
|
Country | SA |
Market Cap | 98B SAR |
Net Margin |
22%
|
Country | ZA |
Market Cap | 24.9B Zac |
Net Margin |
17%
|
Country | ZA |
Market Cap | 20.7B Zac |
Net Margin |
5%
|
Country | CN |
Market Cap | 133.2B CNY |
Net Margin |
18%
|
Country | MY |
Market Cap | 63.3B MYR |
Net Margin |
11%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
15%
|
Country | US |
Market Cap | 13.1B USD |
Net Margin |
7%
|
Country | TH |
Market Cap | 421.1B THB |
Net Margin |
15%
|
Country | IN |
Market Cap | 997.2B INR |
Net Margin |
5%
|
Metro Healthcare Indonesia Tbk PT
Glance View
PT Metro Healthcare Indonesia Tbk engages in the provision of integrated healthcare services. The company is headquartered in Tangerang, Banten and currently employs 713 full-time employees. The company went IPO on 2020-03-13. The firm operates its business in an integrated health service with hospital under Metro Hospital Group. The company is focused on developing technology-based health services and training centers to produce professionals in health services. The firm offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The firm operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, RSIA Mitra Husada, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Metro Hospitals Indonesia, PT Metro Mitra Sarana, PT Eka Tunggal Jaya, PT Paramudya Dasa Sakti, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari, and PT Berkarya Sejahtera Gemilang.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Metro Healthcare Indonesia Tbk PT's most recent financial statements, the company has Net Margin of -37.1%.